STOCKHOLDERS’ EQUITY |
3 Months Ended |
|---|---|
Feb. 28, 2026 | |
| Equity [Abstract] | |
| STOCKHOLDERS’ EQUITY | Note 10 - STOCKHOLDERS’ EQUITY
On June 16, 2025, principal of $618,000 and accrued interest of $56,925 through June 16, 2025 of the February 8, 2024 convertible promissory note with USMC were converted into shares of the Company’s common stock at a conversion price of $0.08 per share.
On June 16, 2025, principal of $1,000,000 and accrued interest of $75,928 through June 16, 2025 of the March 7, 2024 line of credit with USMC were converted into shares of the Company’s common stock at a conversion price of $0.08 per share.
On June 16, 2025, principal of $416,449 and accrued interest of $10,360 through June 16, 2025 of 2025 advances from USMC were converted into shares of the Company’s common stock at a conversion price of $0.08 per share.
On June 24, 2025, shares of the Company’s common stock were issued at $ per share to Brady Barto, a former director, in lieu of $17,000 accrued board compensation.
On July 28, 2025, shares of the Company’s common stock were due to be authorized at $per share in accordance with the July 28, 2025 note payable with J.J. Astor. The shares are included in the stated in the balance sheet for February 28, 2026 but are not included in the 277,968,151 stated on the cover page.
On October 26, 2025, shares of the Company’s common stock were due to be authorized at $ per share in accordance with the July 28, 2025 note payable with J.J. Astor. The shares are included in the stated in the balance sheet for February 28, 2026 but are not included in the 277,968,151 stated on the cover page.
|